NLS Pharmaceutics (NLSP) said Wednesday it priced a private placement offering of up to 322,580 common shares at $3.10 per share for gross proceeds of up to $1 million.
The company said the initial closing of the offering amounting to $500,000 is expected to take place on or before Jan. 10, 2025.
At the election of the buyer, the subsequent closing of $500,000 may happen within 15 days after the receipt of shareholder approval and the common shares trading for at least 10 straight trading days higher than $3.10, corresponding to a premium of about 15%, the company added.
NLS plans to use the net proceeds for general corporate purposes.
The shares of NLS Pharmaceutics were up nearly 2% in recent trading.
Price: 2.74, Change: +0.04, Percent Change: +1.67
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.